Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney Memory and Aging Study

Aging Cell

Volumn 12, Issue 5, 2013, Pages 882-889

  Fuchs, Talia ^a   Trollor, Julian N ^a,b   Crawford, John ^b   Brown, David A ^a   Baune, Bernhard T ^c   Samaras, Katherine ^d,e   Campbell, Lesley ^d,e   Breit, Samuel N ^a   Brodaty, Henry ^b   Sachdev, Perminder ^b,f   Smith, Evelyn ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Aging; Cognitive decline; Dementia; Growth differentiation factor 15; Inflammation; Macrophage inhibitory cytokine 1; Mild cognitive impairment

Indexed keywords

APOLIPOPROTEIN E4; C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; AGED; ANGINA PECTORIS; ARTICLE; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DEPRESSION; DETERIORATION; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; FRAMINGHAM RISK SCORE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEOPLASM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; VELOCITY;

ANGINA;

AGING; COGNITIVE DECLINE; DEMENTIA; GROWTH DIFFERENTIATION FACTOR-15; INFLAMMATION; MACROPHAGE INHIBITORY CYTOKINE-1; MILD COGNITIVE IMPAIRMENT;

AGED; AGED, 80 AND OVER; AGING; COGNITION; COGNITION DISORDERS; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; MALE; MEMORY;

EID: 84883755002     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12116     Document Type: Article

References (45)

1. Alvarez A, Cacabelos R, Sanpedro C, Garcia-Fantini M, Aleixandre M (2007) Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol. Aging 28, 533-536. doi:10.1016/j.neurobiolaging.2006.02.012.
2. Baune BT, Rothermundt M, Ladwig KH, Meisinger C, Berger K (2011) Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO Study. Age (Dordr) 33, 209-217. doi:10.1007/s11357-010-9165-5.
3. Bauskin AR, Brown DA, Kuffner T, Johnen H, Luo XW, Hunter M, Breit SN (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. [Review]. Cancer Res. 66, 4983-4986. doi:10.1158/0008-5472.CAN-05-4067.
4. Benton AL (1967) Problems of test construction in the field of aphasia. Cortex 3, 32-58.
5. Benton Sivan A, Spreen O (1996) Der benton test, 7th edn. Bern: Huber.
6. Breit SN, Johnen H, Cook AD, Tsai VW, Mohammad MG, Kuffner T, Brown DA (2011) The TGF-beta superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors 29, 187-195. doi:10.3109/08977194.2011.607137.
7. Brown DA, Bauskin AR, Fairlie WD, Smith MD, Liu T, Xu N, Breit SN (2002) Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques 33, 118-120.
8. Butcher SK, Lord JM (2004) Stress responses and innate immunity: aging as a contributory factor. Aging Cell 3, 151-160. doi:10.1111/j.1474-9728.2004.00103.x.
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
10. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM (2005) C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112, 900-905. doi:10.1161/CIRCULATIONAHA.104.506337.
11. Dimopoulos N, Piperi C, Salonicioti A, Mitropoulos P, Kallai E, Liappas I, Kalofoutis A (2006) Indices of low-grade chronic inflammation correlate with early cognitive deterioration in an elderly Greek population. Neurosci. Lett. 398, 118-123. doi:10.1016/j.neulet.2005.12.064.
12. Eggers KM, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Jantzen F, Wallentin L (2010) Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome. Circ. Cardiovasc. Genet. 3, 88-96. doi:10.1161/CIRCGENETICS.109.877456.
13. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch. Neurol. 61, 668-672. doi:10.1001/archneur.61.5.668.
14. Fastenau PS, Denburn NL, Mauer BA (1998) Parallel short forms for the Boston Naming Test: psychometric properties and norms for older adults. J. Clin. Exp. Neuropsychol. 20, 828-834.
15. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
16. Gunning-Dixon FM, Brickman AM, Cheng JC, Alexopoulos GS (2009) Aging of cerebral white matter: a review of MRI findings. Int. J. Geriatr. Psychiatry. 24, 109-117. doi:10.1002/gps.2087.
17. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. [Research Support, U.S. Gov't, P.H.S.]. J. Lipid Res. 31, 545-548.
18. Johnen H, Kuffner T, Brown DA, Wu BJ, Stocker R, Breit SN (2012) Increased expression of the TGF-b superfamily cytokine MIC-1/GDF15 protects ApoE (-/-) mice from the development of atherosclerosis. Cardiovasc. Pathol. 21, 499-505. doi:10.1016/j.carpath.2012.02.003.
19. Kaplan E, Goodglass H, Weintraub S (2001) The Boston naming test: Lippincott Williams and Wilkins. Philadelphia.
20. Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, Goggins M (2004) Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin. Cancer Res. 10, 2386-2392.
21. Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, Jagust WJ (2010) Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75, 230-238. doi:10.1212/WNL.0b013e3181e8e8b8.
22. Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, 4th edn. New York: Oxford University Press.
23. Licastro F, Pedrini S, Caputo L, Annoni G, Davis LJ, Ferri C, Grimaldi LM (2000) Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J. Neuroimmunol. 103, 97-102.
24. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS (2009) Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation 119, 3078-3084. doi:10.1161/CIRCULATIONAHA.108.816694.
25. Reitan RM, Wolfson D (1993) The halstead-reitan neuro-psychological test battery: theory and clinical interpretation. Neuropsychological press: Tucson.
26. Rey A (1964) L'examen clinique en psychologie: presses universitaires de france. Presses Universitaires de France: Paris.
27. Roberts RO, Geda YE, Knopman DS, Boeve BF, Christianson TJ, Pankratz VS, Petersen RC (2009) Association of C-reactive protein with mild cognitive impairment. Alzheimers Dement. 5, 398-405. doi:10.1016/j.jalz.2009.01.025.
28. Sachdev PS, Brodaty H, Reppermund S, Kochan NA, Trollor JN, Draper B, Lux O (2010) The sydney memory and ageing study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int. Psychogeriatr. 22, 1248-1264. doi:10.1017/S1041610210001067.
29. Schober A, Bottner M, Strelau J, Kinscherf R, Bonaterra GA, Barth M, Unsicker K (2001) Expression of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain. J. Comp. Neurol. 439, 32-45. doi:10.1002/cne.1333.
30. Selkoe DJ (2012) Preventing Alzheimer's disease. Science 337, 1488-1492.
31. Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK (2010) Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene 29, 1293-1302. doi:10.1038/onc.2009.420.
32. Sheikh JI, Yesavage JA, Brooks JO 3rd, Friedman L, Gratzinger P, Hill RD, Crook T (1991) Proposed factor structure of the geriatric depression scale. Int. Psychogeriatr. 3, 23-28.
33. Shnaper S, Desbaillets I, Brown DA, Murat A, Migliavacca E, Schluep M, Hegi ME (2009) Elevated levels of MIC-1/GDF15 in the cerebrospinal fluid of patients are associated with glioblastoma and worse outcome. Int. J. Cancer 125, 2624-2630. doi:10.1002/ijc.24639.
34. Spreen O, Benton AL (1969) Neurosensory center comprehensive examination for Aphasia: manual of instructions (NCCEA). University of Victoria: Victoria.
35. Strelau J, Bottner M, Lingor P, Suter-Crazzolara C, Galter D, Jaszai J, Unsicker K (2000) GDF-15/MIC-1 a novel member of the TGF-beta superfamily. [Review]. J. Neural Transm. Suppl. 60, 273-276.
36. Stroop JR (1935) Studies of interference in serial verbal reactions. J. Exp. Psychol. 18, 643-662.
37. Trollor JN, Smith E, Agars E, Kuan SA, Baune BT, Campbell L, Sachdev P (2011) The association between systemic inflammation and cognitive performance in the elderly: the sydney memory and ageing study. Age (Dordr) 34, 1295-1308. doi:10.1007/s11357-011-9301-x.
38. Wechsler D (1981) Wechsler adult intelligence scale - revised. San Antonio, TX: Psychological Corporation.
39. Wechsler D (1997a) Wechsler adult intelligence scale-III: The psychological corporation. San Antonio.
40. Wechsler D (1997b) Wechsler memory scale 3rd edn. San Antonio, TX: Psychological Corporation.
41. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Morris JC (2009) The Alzheimer's disease centers' uniform data set (UDS): the neuropsychological test battery. Alzheimer Dis. Assoc. Disord. 23, 91-101. doi:10.1097/WAD.0b013e318191c7dd.
42. Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L, Brown DA (2010) Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell 9, 1057-1064. doi:10.1111/j.1474-9726.2010.00629.x.
43. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blenlow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment - beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J. Intern. Med. 256, 240-246.
44. Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N, Wallentin L (2007) Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 115, 962-971. doi:10.1161/CIRCULATIONAHA.106.650846.
45. Zuliani G, Cavalieri M, Galvani M, Passaro A, Munari MR, Bosi C, Fellin R (2008) Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J. Neurol. Sci. 272, 164-170. doi:10.1016/j.jns.2008.05.020.